Submission Instruction
Journal of Rejuvenation is a peer-reviewed scientific journal focusing on the rejuvenation therapies. It operates in a continuous publication (CP) mode where articles are posted online as soon as they have completed the production process. The Journal of Rejuvenation publishes innovative research aimed at understanding and potentially slowing or reversing the aging process. The journal covers a diverse array of topics, from cardiovascular aging and DNA repair to stem cell research and tissue engineering.
Submission guidelines for the Journal of Rejuvenation, emphasizing key aspects of the manuscript preparation and submission process:
Manuscript Preparation and Submission
Types of Publications
Journal of Rejuvenation accepts various article types, including:
- Editorial
- Review Article
- Original Article
- Short Communication
- Letter to Editor
Each type of publication has distinct structural and content requirements that authors must adhere to facilitate a smooth review process.
Submission Process
Manuscripts should be submitted online via the journal's submission system. The submitting author is responsible for ensuring all co-authors are included and have approved the manuscript. This collaborative approach is crucial in maintaining academic integrity and transparency throughout the process.
Manuscript Format
- Authors are encouraged to use provided Microsoft Word template.
- Free format submission is accepted, but manuscripts must contain essential sections.
- References should be consistently formatted, with DOI numbers encouraged.
Author Information
authors are encouraged to provide a brief biography, as well as accurate affiliation information, as this information is critical for indexing purposes. Additionally, authors should ensure that their ORCID profiles are linked in the final publication to promote transparency and recognition of their work.
Additional Requirements
Authors are also required to submit a cover letter that outlines the significance of their manuscript and its fit within the journal's scope. This cover letter serves as a valuable introduction to the submission and can highlight the contribution that the research makes to the field of rejuvenation therapies. Moreover, adherence to file format and size limitations is essential, as is the proper handling of any supplementary materials that may accompany the manuscript.
Length Considerations
Adherence to prescribed word count limits for various article types is strongly recommended. The main body text, including footnotes and in-text citations, constitutes the manuscript's length. Excluded elements include the abstract, section headings, figure and table captions, funding declarations, acknowledgments, and bibliographic references. Authors should indicate the word count and number of figures and tables on the initial page.
Linguistic Preferences
In terms of linguistic preferences, the Journal of Rejuvenation favors American English for submissions. Authors are advised to consult the Chicago Manual of Style for any stylistic inquiries or guidance, ensuring that their writing adheres to high standards of clarity and professionalism.
Enhancing Discoverability
To enhance the discoverability of their articles, authors are encouraged to incorporate relevant keywords into their article titles while avoiding excessively long titles that may hinder search engine optimization. Selecting 5-8 keywords that strike a balance between general and specific terms is recommended, with these keywords utilized effectively throughout the abstract and primary headings of the manuscript.
Version Control Policy
The journal employs CrossMark to maintain content integrity and inform readers of any modifications. The CrossMark logo provides access to current document status and additional publication information.
Title Composition
When composing titles, authors should aim for conciseness while avoiding implicit terms and abbreviations. The title should effectively convey the main findings or conclusions of the research. While creative titles are permissible, they must remain relevant and appropriate to the content. Authors should avoid purely interrogative titles, ambiguous phrasing, and irrelevant taxonomic information that can detract from the clarity of the title.
Author Information
Author names and affiliations should be presented accurately for indexing purposes. The corresponding author(s) should be denoted with an asterisk, and their contact email provided separately.
Collaborative Authorship
Consortium or group authorship should be clearly indicated, with individual collaborators listed in a dedicated section for proper indexing.
Abstract Composition
The abstract serves as a critical component of the manuscript, elucidating the significance of the work and its conceptual advancements for a broad readership. Authors are advised to minimize the use of abbreviations and to avoid including citations within the abstract, making it accessible to a wider audience.
Keyword Selection
A minimum of 5 and maximum of 8 keywords are required for all article types.
Formatting Requirements
Manuscripts should be single-spaced with page and line numbers, composed in Word Document.
Nomenclature and Units
Abbreviation usage should be limited and defined upon first use. Gene symbols should be italicized and follow approved nomenclature. Standard International Units are encouraged, and systematic nomenclature should be used for chemical compounds and biomolecules.
Structural Organization
Manuscripts should be organized with appropriate headings and subheadings, with up to five levels permitted. For original research articles, the recommended structure includes:
Introduction: The introduction should provide a brief overview of the study within a wider context, emphasizing its significance. It must articulate the study's objectives and importance, including the specific hypotheses being examined. A thorough review of the current landscape of the research field is essential, with key literature referenced. Controversial or differing hypotheses should be noted when relevant. Additionally, the primary goal of the study should be stated, along with a summary of the main findings, ensuring the introduction remains accessible to scientists from other disciplines.
Materials and Methods: This section should include enough detail to enable other researchers to replicate and expand upon the findings. Any novel methods and protocols should be described comprehensively, whereas established procedures can be briefly summarized with appropriate citations. Specify the software used, including its version, and clarify whether the associated computer code is available. Any pre-registration codes should also be included.
Results: Present a clear and concise account of the experimental findings, along with their interpretations and the conclusions that can be derived from them.
Discussion: Authors should interpret the results in light of prior research and the initial hypotheses. The implications of the findings should be explored in a broader context, and any limitations of the study should be acknowledged. Possible directions for future research may also be included. This section may be integrated with the Results section if appropriate.
Conclusions: While this section is optional, it may be useful to include it if the discussion is particularly lengthy or intricate.
Figure and Table Presentation Guidelines
All visual elements, including figures, tables, and images, will be published under a Creative Commons Attribution (CC-BY) license, allowing for broader dissemination and sharing of research findings. Authors are responsible for obtaining the necessary permissions for any copyrighted material sourced externally, ensuring compliance with citation requirements and covering any associated fees.
Figures should be submitted individually in the order they appear within the manuscript, with each figure referenced numerically in the text. For multi-panel figures, authors should use alphabetical labels (A, B, C, etc.) without overlapping the image content, ensuring clarity and readability. Graphs must include self-explanatory axis labels with units to facilitate understanding.
Upon acceptance, high-resolution files in formats such as EPS, JPEG, or TIFF may be required for publication. Figure captions should be placed at the end of the manuscript, preceded by the appropriate label (e.g., "Figure 1."), and panel references should be clearly indicated using bold capital letters in parentheses.
Image Specifications and Accessibility Considerations
When designing figures, authors should keep the PDF layout in mind, ensuring that figures do not exceed one page in length and are appropriately sized for either one-column (85 mm) or two-column (180 mm) formats. A minimum resolution of 300 dpi at final size is required to ensure clarity, with text legibility maintained at no less than 12 points in height. Line thickness should be at least 2 points wide to ensure visibility.
Accessibility considerations are also important, as authors are encouraged to enhance the usability of visual elements for visually impaired readers. This includes ensuring sufficient contrast between text and background, avoiding color combinations that may be difficult for color-blind readers (such as red-green), and using multiple visual cues to convey information effectively in complex graphics.
References
References should be organized numerically based on their order of appearance in the text, including table captions and figure legends, and should be listed separately at the end of the manuscript. To minimize errors and ensure no duplicate references, it is advisable to utilize bibliography management software like EndNote, ReferenceManager, or Zotero. We also advocate for the citation of data, computer code, and other research materials that can be referenced. For online resources, please refer to style 9 below.
Citations and references included in supplementary materials are allowed as long as they are also present in the main text and in the reference list.
Within the text, reference numbers should be enclosed in square brackets [ ], positioned before any punctuation; examples include [1], [1–3], or [1,3]. For citations that include page numbers, both parentheses and brackets should be used to denote the reference number and page numbers, such as [5] (p. 10) or [6] (pp. 101–105).
The reference list should follow the Vancouver system for in-text citations. It should include only published or accepted works, with specific formatting guidelines for various types of sources including journal articles, books, abstracts, websites, patents, datasets, thesis, and preprints.
Acknowledgments
This section should briefly recognize contributions from colleagues, institutions, or agencies. Previous online appearances of the manuscript content should be mentioned here and in the references.
Ethical Considerations
The Journal of Rejuvenation places a strong emphasis on ethical considerations in research and publication. Authors must confirm that their manuscript is not currently under consideration by other journals, that all authors have approved the submission, and that ethical guidelines have been adhered to throughout the research process.
Research Ethics
Human Subjects Research: Researchers involving human participants, materials, tissues, or data must ensure compliance with the Declaration of Helsinki, established in 1975 and updated in 2013. Article 23 mandates approval from a local Institutional Review Board (IRB) or ethics committee before research initiation. The manuscript's 'Institutional Review Board Statement' must include a project identification code, approval date, and ethics committee name.
For observational studies (e.g., surveys), participants must be informed about anonymity, nature of the research, data use, and potential risks. Ethical approval is required, or authors must provide documentation of exemption from the ethics committee, stating relevant local laws. If exempted, the ethics committee's name and reason for exemption must be indicated.
Informed Consent Statement: Studies must declare informed consent for participation; verbal consent may be acceptable in certain contexts (e.g., ethnographic studies). The rationale for verbal consent should be included in the “Informed Consent Statement.” For identifiable information, written consent for publication is required before submission to the Journal of Rejuvenation. Authors must submit a blank consent form, and consent must allow unrestricted publication in all formats. Identifying information should be minimized, and patient details must be anonymized whenever possible. Editors may reject submissions that do not comply with these guidelines.
Clinical Trials Registration: Clinical trials must follow policies regarding human subjects and adhere to ICMJE guidelines, requiring registration in a public registry before or at the first patient enrollment. Authors must pre-register trials with an international registry and include details in the IRB statement or methods section. Observational studies do not require registration, but exceptions must be disclosed. Approval from an independent review body does not replace registration requirements.
Reporting Guidelines for Randomized Clinical Trials: Journal of Rejuvenation requires a completed CONSORT 2010 checklist and flow diagram for reporting randomized clinical trial outcomes. Clinical trial reports should address each checklist item.
Ethical Guidelines for Animal Research: Research involving animals must demonstrate significant benefits relative to costs. Authors must comply with the '3Rs': Replacement, Reduction, and Refinement. Manuscripts should detail housing, husbandry, and pain management practices. The journal supports the ARRIVE guidelines for reporting animal research. Ethical approval is required where national laws dictate, and authors must justify their work ethically if no ethics committee is available for review.
Research Involving Cell Lines: Submissions involving cell lines must specify their source. For established lines, the provenance should be referenced. If novel cell lines are used, details of the IRB approval and informed consent must be included.
Research Involving Plants: Research involving plants must follow relevant guidelines, and authors should provide genetic information and origin. For rare plants, voucher specimens should be deposited in a public repository. Editors may reject submissions not meeting these criteria.
Dual Use Research of Concern: The journal adheres to COPE guidelines, requiring that research posing risks to public health or national security be identified in the manuscript. Authors must ensure compliance with relevant laws.
Sex and Gender in Research: Authors should follow the SAGER guidelines, distinguishing between sex and gender. Article titles and abstracts should clearly state applicable sex(es), and authors must discuss any expected differences based on these factors. If no analysis was performed, a rationale should be provided.
Disputes over Borders and Territories: Authors should approach potential disputes regarding borders and territories with respect. Editorial decisions will strive for resolutions accommodating all parties involved.
Funding: It is essential to disclose all funding sources related to the study. Please specify any grants received to support your research and whether funding was provided for publication expenses. Be aware that some funding entities may not reimburse article processing charges (APC) unless the funder and grant number are accurately stated in the manuscript. Authors can enter funding details separately during the manuscript submission process. If the manuscript is published, this funding information will be submitted to FundRef. Please include one of the following statements: “This research received no external funding,” “This research was funded by [funder name] grant number [xxx],” or “The APC was funded by [XXX].” Ensure that all provided details are correct and utilize the standard spelling for funding agency names found at https://search.crossref.org/funding, as inaccuracies might impact future funding opportunities.
Institutional Review Board Statement: For studies involving human or animal subjects, please include the Institutional Review Board Statement along with the approval number. The Editorial Office may request additional details. You should state, “The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of [INSTITUTE NAME] (protocol code [XXX] and date of approval),” OR “Ethical review and approval were waived for this study due to [REASON] (provide detailed justification),” OR “Not applicable” for studies that do not involve humans or animals. You may also choose to omit this statement for studies that do not involve human or animal subjects.
Informed Consent Statement: Any research article detailing a study with human participants must include this statement. Please state, “Informed consent was obtained from all subjects involved in the study,” OR “Patient consent was waived due to [REASON] (provide detailed justification),” OR “Not applicable” for studies that do not involve human subjects. You may choose to exclude this statement if the study does not involve human participants. For studies involving identifiable patients, written informed consent for publication must be acquired. If applicable, please include, “Written informed consent has been obtained from the patient(s) to publish this paper.”
Data Availability Statement: In this section, please specify where the data supporting the reported findings can be accessed, including links to publicly archived datasets that were analyzed or created during the study. Refer to the recommended Data Availability Statements in the “Journal of Rejuvenation Research Data Policies” section. If no data is reported in the study, you may opt to exclude this statement.
Conflicts of Interest: Authors are required to disclose any personal circumstances or interests that could be perceived as influencing the interpretation or representation of research findings. If there are no conflicts of interest, please state, “The authors declare no conflict of interest.” Additionally, any involvement of funding sponsors in the selection of research projects, study design, data collection, analysis, manuscript writing, or publication decisions must be disclosed here. Biomedicines does not accept studies funded in whole or part by the tobacco industry. For industry-funded projects, it is crucial to fully disclose the extent of the funder's involvement. If there is no involvement, please state, “The sponsors had no role in the design, execution, interpretation, or writing of the study.” For further information, please consult the Conflict of Interest guidelines.
Submission guidelines for the Journal of Rejuvenation, emphasizing key aspects of the manuscript preparation and submission process:
Manuscript Preparation and Submission
Types of Publications
Journal of Rejuvenation accepts various article types, including:
- Editorial
- Review Article
- Original Article
- Short Communication
- Letter to Editor
Each type of publication has distinct structural and content requirements that authors must adhere to facilitate a smooth review process.
Submission Process
Manuscripts should be submitted online via the journal's submission system. The submitting author is responsible for ensuring all co-authors are included and have approved the manuscript. This collaborative approach is crucial in maintaining academic integrity and transparency throughout the process.
Manuscript Format
- Authors are encouraged to use provided Microsoft Word template.
- Free format submission is accepted, but manuscripts must contain essential sections.
- References should be consistently formatted, with DOI numbers encouraged.
Author Information
authors are encouraged to provide a brief biography, as well as accurate affiliation information, as this information is critical for indexing purposes. Additionally, authors should ensure that their ORCID profiles are linked in the final publication to promote transparency and recognition of their work.
Additional Requirements
Authors are also required to submit a cover letter that outlines the significance of their manuscript and its fit within the journal's scope. This cover letter serves as a valuable introduction to the submission and can highlight the contribution that the research makes to the field of rejuvenation therapies. Moreover, adherence to file format and size limitations is essential, as is the proper handling of any supplementary materials that may accompany the manuscript.
Length Considerations
Adherence to prescribed word count limits for various article types is strongly recommended. The main body text, including footnotes and in-text citations, constitutes the manuscript's length. Excluded elements include the abstract, section headings, figure and table captions, funding declarations, acknowledgments, and bibliographic references. Authors should indicate the word count and number of figures and tables on the initial page.
Linguistic Preferences
In terms of linguistic preferences, the Journal of Rejuvenation favors American English for submissions. Authors are advised to consult the Chicago Manual of Style for any stylistic inquiries or guidance, ensuring that their writing adheres to high standards of clarity and professionalism.
Enhancing Discoverability
To enhance the discoverability of their articles, authors are encouraged to incorporate relevant keywords into their article titles while avoiding excessively long titles that may hinder search engine optimization. Selecting 5-8 keywords that strike a balance between general and specific terms is recommended, with these keywords utilized effectively throughout the abstract and primary headings of the manuscript.
Version Control Policy
The journal employs CrossMark to maintain content integrity and inform readers of any modifications. The CrossMark logo provides access to current document status and additional publication information.
Title Composition
When composing titles, authors should aim for conciseness while avoiding implicit terms and abbreviations. The title should effectively convey the main findings or conclusions of the research. While creative titles are permissible, they must remain relevant and appropriate to the content. Authors should avoid purely interrogative titles, ambiguous phrasing, and irrelevant taxonomic information that can detract from the clarity of the title.
Author Information
Author names and affiliations should be presented accurately for indexing purposes. The corresponding author(s) should be denoted with an asterisk, and their contact email provided separately.
Collaborative Authorship
Consortium or group authorship should be clearly indicated, with individual collaborators listed in a dedicated section for proper indexing.
Abstract Composition
The abstract serves as a critical component of the manuscript, elucidating the significance of the work and its conceptual advancements for a broad readership. Authors are advised to minimize the use of abbreviations and to avoid including citations within the abstract, making it accessible to a wider audience.
Keyword Selection
A minimum of 5 and maximum of 8 keywords are required for all article types.
Formatting Requirements
Manuscripts should be single-spaced with page and line numbers, composed in Word Document.
Nomenclature and Units
Abbreviation usage should be limited and defined upon first use. Gene symbols should be italicized and follow approved nomenclature. Standard International Units are encouraged, and systematic nomenclature should be used for chemical compounds and biomolecules.
Structural Organization
Manuscripts should be organized with appropriate headings and subheadings, with up to five levels permitted. For original research articles, the recommended structure includes:
Introduction: The introduction should provide a brief overview of the study within a wider context, emphasizing its significance. It must articulate the study's objectives and importance, including the specific hypotheses being examined. A thorough review of the current landscape of the research field is essential, with key literature referenced. Controversial or differing hypotheses should be noted when relevant. Additionally, the primary goal of the study should be stated, along with a summary of the main findings, ensuring the introduction remains accessible to scientists from other disciplines.
Materials and Methods: This section should include enough detail to enable other researchers to replicate and expand upon the findings. Any novel methods and protocols should be described comprehensively, whereas established procedures can be briefly summarized with appropriate citations. Specify the software used, including its version, and clarify whether the associated computer code is available. Any pre-registration codes should also be included.
Results: Present a clear and concise account of the experimental findings, along with their interpretations and the conclusions that can be derived from them.
Discussion: Authors should interpret the results in light of prior research and the initial hypotheses. The implications of the findings should be explored in a broader context, and any limitations of the study should be acknowledged. Possible directions for future research may also be included. This section may be integrated with the Results section if appropriate.
Conclusions: While this section is optional, it may be useful to include it if the discussion is particularly lengthy or intricate.
Figure and Table Presentation Guidelines
All visual elements, including figures, tables, and images, will be published under a Creative Commons Attribution (CC-BY) license, allowing for broader dissemination and sharing of research findings. Authors are responsible for obtaining the necessary permissions for any copyrighted material sourced externally, ensuring compliance with citation requirements and covering any associated fees.
Figures should be submitted individually in the order they appear within the manuscript, with each figure referenced numerically in the text. For multi-panel figures, authors should use alphabetical labels (A, B, C, etc.) without overlapping the image content, ensuring clarity and readability. Graphs must include self-explanatory axis labels with units to facilitate understanding.
Upon acceptance, high-resolution files in formats such as EPS, JPEG, or TIFF may be required for publication. Figure captions should be placed at the end of the manuscript, preceded by the appropriate label (e.g., "Figure 1."), and panel references should be clearly indicated using bold capital letters in parentheses.
Image Specifications and Accessibility Considerations
When designing figures, authors should keep the PDF layout in mind, ensuring that figures do not exceed one page in length and are appropriately sized for either one-column (85 mm) or two-column (180 mm) formats. A minimum resolution of 300 dpi at final size is required to ensure clarity, with text legibility maintained at no less than 12 points in height. Line thickness should be at least 2 points wide to ensure visibility.
Accessibility considerations are also important, as authors are encouraged to enhance the usability of visual elements for visually impaired readers. This includes ensuring sufficient contrast between text and background, avoiding color combinations that may be difficult for color-blind readers (such as red-green), and using multiple visual cues to convey information effectively in complex graphics.
References
References should be organized numerically based on their order of appearance in the text, including table captions and figure legends, and should be listed separately at the end of the manuscript. To minimize errors and ensure no duplicate references, it is advisable to utilize bibliography management software like EndNote, ReferenceManager, or Zotero. We also advocate for the citation of data, computer code, and other research materials that can be referenced. For online resources, please refer to style 9 below.
Citations and references included in supplementary materials are allowed as long as they are also present in the main text and in the reference list.
Within the text, reference numbers should be enclosed in square brackets [ ], positioned before any punctuation; examples include [1], [1–3], or [1,3]. For citations that include page numbers, both parentheses and brackets should be used to denote the reference number and page numbers, such as [5] (p. 10) or [6] (pp. 101–105).
The reference list should follow the Vancouver system for in-text citations. It should include only published or accepted works, with specific formatting guidelines for various types of sources including journal articles, books, abstracts, websites, patents, datasets, thesis, and preprints.
Acknowledgments
This section should briefly recognize contributions from colleagues, institutions, or agencies. Previous online appearances of the manuscript content should be mentioned here and in the references.
Ethical Considerations
The Journal of Rejuvenation places a strong emphasis on ethical considerations in research and publication. Authors must confirm that their manuscript is not currently under consideration by other journals, that all authors have approved the submission, and that ethical guidelines have been adhered to throughout the research process.
Research Ethics
Human Subjects Research: Researchers involving human participants, materials, tissues, or data must ensure compliance with the Declaration of Helsinki, established in 1975 and updated in 2013. Article 23 mandates approval from a local Institutional Review Board (IRB) or ethics committee before research initiation. The manuscript's 'Institutional Review Board Statement' must include a project identification code, approval date, and ethics committee name.
For observational studies (e.g., surveys), participants must be informed about anonymity, nature of the research, data use, and potential risks. Ethical approval is required, or authors must provide documentation of exemption from the ethics committee, stating relevant local laws. If exempted, the ethics committee's name and reason for exemption must be indicated.
Informed Consent Statement: Studies must declare informed consent for participation; verbal consent may be acceptable in certain contexts (e.g., ethnographic studies). The rationale for verbal consent should be included in the “Informed Consent Statement.” For identifiable information, written consent for publication is required before submission to the Journal of Rejuvenation. Authors must submit a blank consent form, and consent must allow unrestricted publication in all formats. Identifying information should be minimized, and patient details must be anonymized whenever possible. Editors may reject submissions that do not comply with these guidelines.
Clinical Trials Registration: Clinical trials must follow policies regarding human subjects and adhere to ICMJE guidelines, requiring registration in a public registry before or at the first patient enrollment. Authors must pre-register trials with an international registry and include details in the IRB statement or methods section. Observational studies do not require registration, but exceptions must be disclosed. Approval from an independent review body does not replace registration requirements.
Reporting Guidelines for Randomized Clinical Trials: Journal of Rejuvenation requires a completed CONSORT 2010 checklist and flow diagram for reporting randomized clinical trial outcomes. Clinical trial reports should address each checklist item.
Ethical Guidelines for Animal Research: Research involving animals must demonstrate significant benefits relative to costs. Authors must comply with the '3Rs': Replacement, Reduction, and Refinement. Manuscripts should detail housing, husbandry, and pain management practices. The journal supports the ARRIVE guidelines for reporting animal research. Ethical approval is required where national laws dictate, and authors must justify their work ethically if no ethics committee is available for review.
Research Involving Cell Lines: Submissions involving cell lines must specify their source. For established lines, the provenance should be referenced. If novel cell lines are used, details of the IRB approval and informed consent must be included.
Research Involving Plants: Research involving plants must follow relevant guidelines, and authors should provide genetic information and origin. For rare plants, voucher specimens should be deposited in a public repository. Editors may reject submissions not meeting these criteria.
Dual Use Research of Concern: The journal adheres to COPE guidelines, requiring that research posing risks to public health or national security be identified in the manuscript. Authors must ensure compliance with relevant laws.
Sex and Gender in Research: Authors should follow the SAGER guidelines, distinguishing between sex and gender. Article titles and abstracts should clearly state applicable sex(es), and authors must discuss any expected differences based on these factors. If no analysis was performed, a rationale should be provided.
Disputes over Borders and Territories: Authors should approach potential disputes regarding borders and territories with respect. Editorial decisions will strive for resolutions accommodating all parties involved.
Funding: It is essential to disclose all funding sources related to the study. Please specify any grants received to support your research and whether funding was provided for publication expenses. Be aware that some funding entities may not reimburse article processing charges (APC) unless the funder and grant number are accurately stated in the manuscript. Authors can enter funding details separately during the manuscript submission process. If the manuscript is published, this funding information will be submitted to FundRef. Please include one of the following statements: “This research received no external funding,” “This research was funded by [funder name] grant number [xxx],” or “The APC was funded by [XXX].” Ensure that all provided details are correct and utilize the standard spelling for funding agency names found at https://search.crossref.org/funding, as inaccuracies might impact future funding opportunities.
Institutional Review Board Statement: For studies involving human or animal subjects, please include the Institutional Review Board Statement along with the approval number. The Editorial Office may request additional details. You should state, “The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of [INSTITUTE NAME] (protocol code [XXX] and date of approval),” OR “Ethical review and approval were waived for this study due to [REASON] (provide detailed justification),” OR “Not applicable” for studies that do not involve humans or animals. You may also choose to omit this statement for studies that do not involve human or animal subjects.
Informed Consent Statement: Any research article detailing a study with human participants must include this statement. Please state, “Informed consent was obtained from all subjects involved in the study,” OR “Patient consent was waived due to [REASON] (provide detailed justification),” OR “Not applicable” for studies that do not involve human subjects. You may choose to exclude this statement if the study does not involve human participants. For studies involving identifiable patients, written informed consent for publication must be acquired. If applicable, please include, “Written informed consent has been obtained from the patient(s) to publish this paper.”
Data Availability Statement: In this section, please specify where the data supporting the reported findings can be accessed, including links to publicly archived datasets that were analyzed or created during the study. Refer to the recommended Data Availability Statements in the “Journal of Rejuvenation Research Data Policies” section. If no data is reported in the study, you may opt to exclude this statement.
Conflicts of Interest: Authors are required to disclose any personal circumstances or interests that could be perceived as influencing the interpretation or representation of research findings. If there are no conflicts of interest, please state, “The authors declare no conflict of interest.” Additionally, any involvement of funding sponsors in the selection of research projects, study design, data collection, analysis, manuscript writing, or publication decisions must be disclosed here. Biomedicines does not accept studies funded in whole or part by the tobacco industry. For industry-funded projects, it is crucial to fully disclose the extent of the funder's involvement. If there is no involvement, please state, “The sponsors had no role in the design, execution, interpretation, or writing of the study.” For further information, please consult the Conflict of Interest guidelines.
Before submission, make sure your manuscript aligns with the journal's scope and that you have selected the appropriate article type. Submissions that do not fit the scope or are of the incorrect article type may face delays or rejection. During the submission, the submitting author will need to respond to questions about the manuscript and research, as well as provide information and consent from all authors.
View: 185 Time(s) | Print: 25 Time(s) | Email: 0 Time(s) |
0 Comment(s)
